7[2]Wu WH, Ma S, Lin JT, et al. Surgical treatment of axillary osmidrosis : a n analysis of 343 cases[J]. Plast Reconstr Surg, 1994, 94(2): 288.
8[3]Yoshikata R, Yanai A, Takei T, et al. Surgical treatment of axillary osmi drosis[J]. Br J Plast Surg, 1990, 43(4): 483.
9Hibi M,Lin A,Smeal T,et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain[J]. Genes Dev,2007,(11 ): 2135-2 !48.
10Davis RJ. Signal transduction by the JNK group of MAP kinases[J]. Cell,2000,103(2):239-252.
5Pinfildi CE,Liebano RE,Hochman BS. Helium-neon laser in viability of random skin flap in rats[J].{H}Lasers in Surgery and Medicine,2005,(01):74-77.
6Amann K,Faulhaber J,Campean V. Impaired myocardial capillarogenesis and increased adaptive capillary growth in FGF2-deficient mice[J].{H}Laboratory Investigation,2006,(01):45-53.
7Li ZR, Sun CW, Zhang JY, et al. Excision of apocrine glands with preservation of axiIlary superficial fascia for the treatment of axillary bromhidrosis[J]. Dermatol Surg, 2015,41 (5) :640-644.
8de Almeida AR, Montagner S. Botulinum toxin for axillary hyper- hidrosis [J]. Dermatol Clin, 2014,32 (4) :495-504.
9RoseU K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyper- hidrosis[J]. Acta Derm Venereol, 2013,93(3) :335-339.
10Glaser DA, Galperin TA. Botulinum toxin for hyperhidrosis of areas other than the axillae and palms/soles [ J ]. Dermatol Clin, 2014,32(4) :517-515.
